FDA approves breakthrough drug for treatment of hepatitis C

FDA approves breakthrough drug for treatment of hepatitis C

Sovaldi (sofosbuvir) is the first drug that has been shown to safely and effectively treat certain types of hepatitis C infection without a need for interferon, the FDA said. Hepatitis C is a viral disease that causes inflammation of the liver, which

6
Like
Save

Comments

Write a comment

*